Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
Boosters are better than they used to be at fitting lap and shoulder belts on 4 to 8-year-old kids to restrain them in a crash - so parents don\'t have to search as hard for a good fit for their child and vehicle. Most belt-positioning boosters, though, don\'t offer consistently good fit in all vehicles. This is the bottom line in the Insurance Institute for Highway Safety\'s third round of booster evaluations.
Researchers assessed the safety belt fit of 72 boosters, assigning the best ones the top ratings of BEST BET or GOOD BET because they correctly position belts on average booster-age kids in most vehicles. The worst performers are ones the Institute doesn\'t recommend because they do a poor job of fitting belts. A good booster routes the lap belt across a child\'s upper thighs and positions the shoulder belt at midshoulder.
As the dust settles from the 2012 International Consumer Electronics Show (CES) in Las Vegas, NV, technologists from around the world have gathered at the IEEE International Consumer Electronics Conference (ICCE) to discuss what’s next for consumer electronics. This annual event is one of the industry’s flagship conferences known for unveiling a plethora of impressive innovations and highlighting upcoming developments. These futuristic concepts are often brought to life within a few years of their debut at ICCE.
While researchers discuss new innovations and technologies for the consumer electronics industry, IEEE experts highlight the trends from CES 2012 that will dictate the product development cycles of companies all around the world.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54152-ieee-discusses-consumer-electronics-trends
The Institute for Business & Home Safety (IBHS) today announced the grand opening of its multi-risk research center in Chester County, S.C.
The state-of-the-art, multi-hazard applied research and training facility will significantly advance building science by enabling researchers to more fully and accurately evaluate various residential and commercial construction materials and systems. The facility is entirely funded by the property insurance industry.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/ibhs/45568/
The secret to having a productive and enjoyable business trip isn't about packing favorite items from home, but rather unplugging from work and exploring the surroundings. As simple as that may seem, researchers at the University of Edinburgh found that taking a walk outside can lessen brain fatigue and frustration, therefore, increasing levels of engagement. It's a notion that some of the savviest business travelers know well, which is why many are investing time and money to enjoy the destinations where business takes them.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7323651-homewood-suites-by-hilton-survey-business-travelers-immerse-local-life/
The Perelman School of Medicine at the University of Pennsylvania and the March of Dimes Foundation announce the launch of a new $10 million Prematurity Research Center here.
The March of Dimes will invest $10 million during the next five years to create a transdisciplinary center conducting team-based research, led by physicians and researchers at the Hospital of the University of Pennsylvania and The Children’s Hospital of Philadelphia, to discover the unknown causes of preterm birth and develop new strategies to prevent it. This March of Dimes Prematurity Research Center at the University of Pennsylvania is part of a “medical Manhattan Project” of five such centers in the United States created by the foundation since 2011.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
According to the results of a recent study conducted by researchers at the USDA-Agricultural Research Service Western Human Nutrition Research Center, the Northwest Cherry Growers are pleased to announce that consuming about 45 (280 g) sweet Bing cherries significantly decreased circulating concentrations of specific inflammatory biomarkers in the blood. According to Dr. Kent Erickson, Professor at UC Davis School of Medicine and a collaborator in the study, “Many studies by other investigators have demonstrated that some of those inflammation markers are associated with increased risk for some chronic diseases such as cardiovascular disease, diabetes, and cancer.” The findings of the study have been published in the March 2013 issue of The Journal of Nutrition.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61851-northwest-cherries-usda-study-health-benefits
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Wiping up finger paint and tackling juice spills is a routine every parent has down pat. Yet they may find themselves playing hide-and-seek with the invisible things little hands leave behind—like bacteria and viruses. Germs stick to all types of surfaces, and kids spread them to more places than you can imagine.
To track down where germs linger, The Clorox Company and global public health organization NSF International conducted a study in homes of families with young children. Researchers analyzed 100 samples from five commonly-touched surfaces, and found bacteria or viruses on all five of the surfaces tested, from the kitchen to the common area to the bathroom, with the bathroom sink being one of the surfaces with the most germs. In fact, the study results found that four times as many households had bathroom sinks that were germier than kitchen countertops.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7359251-clorox-and-nsf-study-shows-which-surfaces-have-most-germs-in-homes-with-kids
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer.
The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
